Summary

The fertility and pregnancy rapid test kits market was valued at $1.5 billion in 2023, and is projected to reach $3.1 billion by 2033, growing at a CAGR of 7.4% from 2024 to 2033.
Fertility and pregnancy rapid test kits are over-the-counter diagnostic tools designed to quickly detect hormones in urine or saliva that indicate a woman's fertility status or pregnancy. These tests provide a convenient and private way for individuals to monitor their reproductive health without the need for a healthcare professional's intervention. Pregnancy test kits detect the presence of human chorionic gonadotropin, a hormone produced during pregnancy, while fertility test kits detect luteinizing hormone or estrogen, which are critical for ovulation.

The global fertility and pregnancy rapid test kits market is witnessing robust growth due to factors such as rise in awareness about reproductive health and the convenience of at-home testing, especially among individuals trying to conceive. In addition, alarming rise in infertility rates due to lifestyle factors and delayed childbearing is driving a greater need for fertility test kits among couples seeking to conceive. According to a study published today by the World Health Organization in 2023, around 17.5% of the adult population experience infertility. The Infertility Statistics 2024 revealed that 48.5 million couples experience infertility globally. This highlights the urgent need for fertility test kits to help individuals monitor their fertility cycles and make informed decision. Moreover, the market growth is significantly driven by the relatively low cost of fertility and pregnancy rapid test kits makes them an affordable option for individuals seeking to monitor their reproductive health without the expense of frequent doctor visits. Furthermore, the widespread availability of these kits in both physical retail stores and online marketplaces makes them easy for consumers to access, thus contributing to the market growth. Early detection of pregnancy, especially for women with irregular cycles or those who want to confirm pregnancy quickly, is further augmenting the demand for pregnancy test kits. Despite advancements, some test kits may still provide false positives or false negatives, which significantly hampers the market growth. In addition, rise of other reproductive health technologies, such as digital ovulation trackers or mobile apps that offer more detailed insights, may reduce the demand for traditional test kits, thereby restraining the market growth. On the contrary, innovations in test kit technology, including greater accuracy, user-friendly designs, and faster results, have expanded the appeal and reliability of these products, which are expected to offer remunerative opportunities for the expansion of the global market during the forecast period. In addition, government initiatives to increase awareness about pregnancy testing as a preventative measure due to rise in burden of unplanned pregnancies and alarming rise in rate of abortion are anticipated to open new avenues for the growth of the market in the coming years. According to a 2022 study published by the World Family Planning, approximately 50% of the women across 41 countries use contraceptives to prevent pregnancy. Among these, 22 countries were from sub-Saharan Africa alone.

The global fertility and pregnancy rapid test kits market is segmented into product, test type, end user, and region. On the basis of the product, the market is bifurcated into pregnancy rapid tests and fertility rapid tests. By test type, it is classified into urine-based test kits and blood-based test kits. Depending on end user, it is divided into hospitals, homecare settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings
By product, the pregnancy rapid tests segment is expected to dominate the market from 2024 to 2033.
On the basis of test type, the urine-based test kits rapid tests segment is anticipated to exhibit the highest growth during the forecast period.
Depending on end user, the homecare settings segment is projected to grow at a notable pace throughout the forecast period.
Region wise, the fertility and pregnancy rapid test kits market is likely to witness strong growth in In North America in the coming years.

Competition Analysis
Competitive analysis and profiles of the major players in the global fertility and pregnancy rapid test kits market include Atlas Medical GmbH, Church & Dwight Co., Inc., Everlywell, Inc., Geratherm Medical AG, QuidelOrtho Corporation, Mylab Discovery Solutions Pvt. Ltd., Salignostics , Abbott, SPD Swiss Precision Diagnostics GmbH, and AdvaCare Pharma. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.


Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● New Product Development/ Product Matrix of Key Players
● Regulatory Guidelines
● Additional company profiles with specific to client's interest
● Additional country or region analysis- market size and forecast
● Average Selling Price Analysis / Price Point Analysis
● Expanded list for Company Profiles
● Historic market data
● Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
● Pregnancy Rapid Tests
● Fertility Rapid Tests
By Test Type
● Urine-based Test Kits
● Blood-based Test Kits
● Others
By End User
● Hospitals
● Homecare Settings
● Others
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ Japan
○ China
○ India
○ Australia
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA
● Key Market Players
○ Atlas Medical GmbH
○ Church & Dwight Co., Inc.
○ Everlywell, Inc.
○ Geratherm Medical AG
○ QuidelOrtho Corporation
○ Mylab Discovery Solutions Pvt. Ltd.
○ Salignostics
○ Abbott
○ SPD Swiss Precision Diagnostics GmbH
○ AdvaCare Pharma

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Pregnancy Rapid Tests
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Fertility Rapid Tests
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY TEST TYPE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Test Type
5.2. Urine-based Test Kits
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Blood-based Test Kits
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Homecare Settings
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Test Type
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Fertility and Pregnancy Rapid Test Kits Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Test Type
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Fertility and Pregnancy Rapid Test Kits Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Test Type
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Fertility and Pregnancy Rapid Test Kits Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Test Type
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Test Type
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Fertility and Pregnancy Rapid Test Kits Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Test Type
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Fertility and Pregnancy Rapid Test Kits Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Test Type
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Fertility and Pregnancy Rapid Test Kits Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Test Type
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Fertility and Pregnancy Rapid Test Kits Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Test Type
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Fertility and Pregnancy Rapid Test Kits Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Test Type
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Fertility and Pregnancy Rapid Test Kits Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Test Type
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Test Type
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Fertility and Pregnancy Rapid Test Kits Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Test Type
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Fertility and Pregnancy Rapid Test Kits Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Test Type
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Fertility and Pregnancy Rapid Test Kits Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Test Type
7.4.8.3. Market Size and Forecast, By End User
7.4.9. Australia Fertility and Pregnancy Rapid Test Kits Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Test Type
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Fertility and Pregnancy Rapid Test Kits Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Test Type
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Fertility and Pregnancy Rapid Test Kits Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Test Type
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Test Type
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Fertility and Pregnancy Rapid Test Kits Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Test Type
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Fertility and Pregnancy Rapid Test Kits Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Test Type
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Fertility and Pregnancy Rapid Test Kits Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Test Type
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Fertility and Pregnancy Rapid Test Kits Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Test Type
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Atlas Medical GmbH
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Church And Dwight Co., Inc.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Everlywell, Inc.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Geratherm Medical AG
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. QuidelOrtho Corporation
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Mylab Discovery Solutions Pvt. Ltd.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Salignostics
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Abbott
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. SPD Swiss Precision Diagnostics GmbH
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. AdvaCare Pharma
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments